OrganoClick AB carries out a set-off issue as compensation for cash board fees - Marketscreener.com
| ORGC Stock | SEK 2.73 0.09 3.19% |
Slightly above 61% of Organoclick's investor base is looking to short. The analysis of current outlook of investing in Organoclick AB suggests that many traders are alarmed regarding Organoclick's prospects. Organoclick's investing sentiment can be driven by a variety of factors including economic data, Organoclick's earnings reports, geopolitical events, and overall market trends.
Organoclick |
OrganoClick AB carries out a set-off issue as compensation for cash board fees Marketscreener.com
Read at news.google.com
 |
Organoclick Fundamental Analysis
We analyze Organoclick's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Organoclick using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Organoclick based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Price To Earning
Price To Earning Comparative Analysis
Organoclick is currently under evaluation in price to earning category among its peers. Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.
Organoclick AB Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Organoclick stock to make a market-neutral strategy. Peer analysis of Organoclick could also be used in its relative valuation, which is a method of valuing Organoclick by comparing valuation metrics with similar companies.
Peers
Organoclick Related Equities
| NEXAM | Nexam Chemical | 1.80 | ||||
| IAR-B | IAR Systems | 1.03 | ||||
| LIPUM | Lipum AB | 0.67 | ||||
| MEKO | Mekonomen | 0.15 | ||||
| ALBERT | EEducation Albert | 0.29 | ||||
| KABE-B | KABE Group | 0.33 | ||||
| AOI | Africa Oil | 0.34 | ||||
| MSON-A | Midsona AB | 0.84 | ||||
| CLS-B | Clinical Laserthermia | 1.45 | ||||
| SALT-B | SaltX Technology | 10.29 |
Additional Tools for Organoclick Stock Analysis
When running Organoclick's price analysis, check to measure Organoclick's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Organoclick is operating at the current time. Most of Organoclick's value examination focuses on studying past and present price action to predict the probability of Organoclick's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Organoclick's price. Additionally, you may evaluate how the addition of Organoclick to your portfolios can decrease your overall portfolio volatility.